Ep 2 The Naturopathic Immune Response with Dr Dan Rubin | Learning How to Fight Cancer

Описание: In the second episode of Learning How to Fight Cancer, Dr. Matt Halpert sits down with Dr. Dan Rubin — pioneer of naturopathic oncology and founder of Naturopathic Specialists — to explore how personalized immunotherapy and immune system engagement are reshaping the cancer care landscape.

Dr. Rubin reflects on 30 years of clinical experience, from early experimentation with dendritic cell therapies in the 1990s to his recent success treating patients with Immunocine’s double-loaded approach. Together, he and Dr. Halpert discuss why cancer must be treated as a whole-body, individualized disease and how aligning with the immune system’s natural intelligence opens powerful new possibilities for advanced-stage patients.

Show Notes / Timestamps:
00:00 – Why dendritic cells align with naturopathic medicine
02:11 – Case spotlight: Stage 4 breast cancer patient improves after Immunocine treatment
06:32 – Lessons from early attempts at personalized immunotherapy
12:23 – Why “double loading” dendritic cells is the critical missing step
17:05 – What truly helps advanced cancer patients: movement, vitality, and mindset
24:29 – The problem with “$30 miracle cures” and unqualified advice
28:54 – What to look for in a legitimate integrative cancer clinic
34:50 – Dr. Rubin’s final message to patients: “Life is sacred. This is cancer. Work with experts.”

Key Resources:
Explore Dr. Dan Rubin’s work: https://listenandcare.com/
Follow Dr. Rubin’s podcast Rubin On Point: https://listenandcare.com/podcast/

----------------------------------------------------------------
Interested in exploring Immunocine's revolutionary Cancer Treatment? Learn more at https://immunocine.com/
----------------------------------------------------------------

The Immunocine Cancer Center provides one of the most advanced Cancer Immunotherapies available. Backed by research and multiple clinical trials, the Immunocine Treatment is meant for the cancer patients of today seeking the cancer treatment of tomorrow.